Ruxolitinib, ATP-competitive JAK1/2 inhibitor from Abcam

Product Specs
ItemRuxolitinib, ATP-competitive JAK1/2 inhibitor
CompanyAbcam
Price Supplier Page View Company Product Page
Catalog Numberab141356
Molecule NameRuxolitinib
TypeInhibitor, inhibitor
Quantity5 mg, 25 mg

Add to Compare List

Abcam

Discovery Drive

Cambridge Biomedical Campus

Cambridge CB2 0AX

United Kingdom

Phone: +44 (0) 1223 696000 (option 1)
+44 (0) 1223 696000 (option 2)
+44 (0) 1223 771600

Company Profile

Website: http://www.abcam.com

(1) Control of retrotransposon-driven activation of the interferon response by the double-stranded RNA binding protein DGCR8Nucleic Acids ResMarch 5, 2026Ana Gázquez-Gutiérrez, Priscilla Chin, Guillermo Peris, Katrina Gordon, Pilar G Marchante, Jeroen Witteveldt, Pablo Tristán-Ramos, Jerome O Rouvière, Lisanne I Knol, Alasdair Ivens, et al.Spearman and Kärber algorithm. For IFN inhibition, cells were incubated with 10 μM of ruxolitinib (ab141356, Abcam) for 1 h pre-infection. Infections were performed as before in serum-free medium containing 10

(2) Disrupted RNA editing in beta cells mimics early-stage type 1 diabetesCell MetabolismJanuary 1, 2024Udi Ehud Knebel, Shani Peleg, Chunhua Dai, Roni Cohen-Fultheim, Sara Jonsson, Karin Poznyak, Maya Israeli, Liza Zamashanski, Benjamin Glaser, Erez Y. Levanon, et al.Master mix,Bio-Rad,Cat# 1725124 TRIzol Reagent,Thermo Fisher,Cat# 15596026 Ruxolitinib,Abcam,Cat# AB-ab141356–25-B GKA,Pfizer,Cat# HY-108328 Diazoxide,Sigma-Aldrich,Cat# D9035–250MG Nifedipine,Sigma-Aldrich,Cat#

(3) Ruxolitinib attenuates secondary injury after traumatic spinal cord injuryNeural regeneration researchSeptember 1, 2022Qian ZY, Kong RY, Zhang S, Wang BY, Chang J, Cao J, Wu CQ, Huang ZY, Duan A, Li HJ, et al.and 1% penicillin-streptomycin (Servicebio), as previously described (Hong et al., 2020). RUX (Cat# ab141356; Abcam, Cambridge, MA, USA) was dissolved in pH 3.5 citrate buffer according to a previous study (Das

(4) Lipidome-based Targeting of STAT3-driven Breast Cancer Cells Using Poly-l-glutamic Acid-coated Layer-by-Layer NanoparticlesMolecular cancer therapeuticsApril 1, 2021Tošić I, Heppler LN, Egusquiaguirre SP, Boehnke N, Correa S, Costa DF, Moore EAG, Pal S, Richardson DS, Ivanov AR, et al.treatment. MCF-10A cells were pre-incubated with 5 µM pyrimethamine (46706, Sigma Aldrich) or 2.5 µM ruxolitinib (ab141356, Abcam) for 4.5 hours. They were then induced with doxycycline (or vehicle control) for 24 hours, prior

Be the First to Write a Review!

Ruxolitinib, ATP-competitive JAK1/2 inhibitor from Abcam

Abcam

Citations (4)

Reviews

Ruxolitinib, ATP-competitive JAK1/2 inhibitor from Abcam

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map